Katrin Beul
Cell therapyInternal medicineUrologyEndocrinologyPathologyCell adhesion moleculeEndogenyProgenitor cellBiopsySoluble fms-like tyrosine kinase-1Bone marrowKidneyKidney transplantationAngiogenesisPathogenesisKidney surgeryRenal fibrosisSdf 1 cxcr4Tube formationBlood volumePhysiologyIschemiaMedicine
4Publications
2H-index
20Citations
Publications 4
Newest
#1Theresa M. WewersH-Index: 1
#2Anna B. MayerH-Index: 3
Last. Giovana Seno Di MarcoH-Index: 19
view all 12 authors...
Renal ischemia reperfusion injury (IRI) adversely affects clinical outcomes following kidney transplantation. Understanding the cellular mechanisms and the changes in gene/protein expression following IRI may help to improve these outcomes. Serum soluble fms-like tyrosine kinase 1 (sFlt-1), a circulating antiangiogenic protein, is increased in the first week following kidney transplantation. We evaluated the casual relationship of elevated sFlt-1 levels with renal microvascular dysfunction follo...
Source
#1Lina GolleH-Index: 2
#2Hans Ulrich GerthH-Index: 12
Last. Marcus BrandH-Index: 17
view all 9 authors...
The reduced number of circulating stem/progenitor cells that is found in chronic kidney disease (CKD) patients may contribute to impaired angiogenic repair and decreased capillary density in the heart. Cell therapy with bone marrow-derived cells (BMDCs) has been shown to induce positive effects on the microvasculature and cardiac function, most likely due to secretion of growth factors and cytokines, all of which are present in the conditioned medium (CM); however, this is controversial. Here we...
Source
#1Lina GolleH-Index: 2
#2Katrin BeulH-Index: 2
Last. Marcus BrandH-Index: 17
view all 5 authors...
Source
#1Lina GolleH-Index: 2
#2Katrin BeulH-Index: 2
Last. Marcus BrandH-Index: 17
view all 5 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.